Source comparison
CJC-1295 no DAC & Ipamorelin 30s Protocol Comparison
Conservative (once-daily pre-sleep) 1× daily 100–150 mcg Maintaining endogenous pulsatility with minimal intervention; ideal for individuals new to GHS protocols Low. Preserves natural pulse structure Best starting point for 30–35 age range with no prior pepti
This comparison does not assign a generated winner or score.
- Conservative (once-daily pre-sleep)
- 1× daily
- 100–150 mcg
- Maintaining endogenous pulsatility with minimal intervention; ideal for individuals new to GHS protocols
- Low. Preserves natural pulse structure
- Best starting point for 30–35 age range with no prior peptide use; allows assessment of individual response before escalation
- Moderate (twice-daily pre-sleep + post-training)
- 2× daily
- 200–300 mcg
- Amplifying both nocturnal and exercise-induced pulses; suited for active individuals with 4+ resistance sessions weekly
- Moderate. Requires 5-day breaks every 4–6 weeks
- Optimal for 32–38 age range with established training protocols; produces measurable body composition changes within 6–8 weeks
- Aggressive (twice-daily high-dose)
- 300–400 mcg
- Overcoming early signs of age-related decline in pulse amplitude; typically reserved for late 30s with documented low-normal IGF-1
- High. Desensitization likely within 4 weeks without cycling
- Not recommended for healthy 30–35 range; risk outweighs benefit unless baseline IGF-1 is <180 ng/mL and natural pulsatility is already compromised